Harm Reduction Journal

Article	Citations
“They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City	175
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic	175
“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives	69
Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)	67
Estimation of the global number of e-cigarette users in 2020	62
What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users	44
Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain	43
Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic	39
Ethical and legal issues in psychedelic harm reduction and integration therapy	39
Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication	38
High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips	37
Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives	37
Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications	35
‘They already operated like it was a crisis, because it always has been a crisis’: a qualitative exploration of the response of one homeless service in Scotland to the COVID-19 pandemic	35
The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services	35
The impact of the COVID-19 pandemic on harm reduction services in Spain	34
A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone	34
Meeting people where they are: implementing hospital-based substance use harm reduction	34
Peer support workers as a bridge: a qualitative study exploring the role of peer support workers in the care of people who use drugs during and after hospitalization	33
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report	33
Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data	33
Practices of care among people who buy, use, and sell drugs in community settings	32
How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review	32
Harm reduction in an emergency response to homelessness during South Africa’s COVID-19 lockdown	30
Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada	29

Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample	28
Opioid overdose crises during the COVID-19 pandemic: implication of health disparities	28
“Running myself ragged”: stressors faced by peer workers in overdose response settings	27
The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19	27
Police discretion in encounters with people who use drugs: operationalizing the theory of planned behavior	26
Who chooses to enroll in a new national gambling self-exclusion system? A general population survey in Sweden	25
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia	25
The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective coh	25
Uptake of COVID-19 vaccination among people who inject drugs	23
Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic	23
The health impact of smokeless tobacco products: a systematic review	22
Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London	22
Cannabis health knowledge and risk perceptions among Canadian youth and young adults	22
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response	22
The impact of cigarette and e-cigarette use history on transition patterns: a longitudinal analysis of the population assessment of tobacco and health (PATH) study, 2013–2015	22
“They say it’s fentanyl, but they honestly look like Perc 30s”: Initiation and use of counterfeit fentanyl pills	21
Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL	21
Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work	21
Results from a 2018 cross-sectional survey in Tokyo, Osaka and Sendai to assess tobacco and nicotine product usage after the introduction of heated tobacco products (HTPs) in Japan	21
Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs	20
Decolonizing drug policy	20
Structural vulnerabilities and HIV risk among sexual minority female sex workers (SM-FSW) by identity and behavior in Baltimore, MD	19
A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs	19
‘I perceive it to be less harmful, I have no idea if it is or not:’ a qualitative exploration of the harm perceptions of IQOS among adult users	19
A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes	19
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era	19
Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City	19
Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)	18
Investigating the impact of COVID-19 on performance and image enhancing drug use	18
Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction	17
Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019–April 2020	17
Therapy of chronic hepatitis C in people who inject drugs: focus on adherence	17
Lisbon’s COVID 19 response: harm reduction interventions for people who use alcohol and other drugs in emergency shelters	17
The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study	17
Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs	16
Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia	16
A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, C	16
Factors associated with drug checking service utilization among people who use drugs in a Canadian setting	16
A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids	16
Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky	15
“My first 48 hours out”: drug users’ perspectives on challenges and strategies upon release from prison	15
Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services	15
High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion	15
Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study	14
Risk factors of infective endocarditis in persons who inject drugs	14
How do naloxone-based interventions work to reduce overdose deaths: a realist review	14
Organizational support for frontline harm reduction and systems navigation work among workers with living and lived experience: qualitative findings from British Columbia, Canada	14
The association between cannabis use and outcome in pharmacological treatment for opioid use disorder	14
Sensory experiences and cues among E-cigarette users	14
Hostility, compassion and role reversal in West Virginia’s long opioid overdose emergency	14

Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis	13
Facilitators and barriers to the regulation of medical cannabis: a scoping review of the peer-reviewed literature	13
New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries	13
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs	13
Lifetime and past-month substance use and injection among street-based female sex workers in Iran	13
Peer-assisted injection as a harm reduction measure in a supervised consumption service: a qualitative study of client experiences	13
Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico	12
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries	12
Providing reproductive health services for women who inject drugs: a pilot program	12
Training to reduce emergency responders’ perceived overdose risk from contact with fentanyl: early evidence of success	12
Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C.	12
Peer driven or driven peers? A rapid review of peer involvement of people who use drugs in HIV and harm reduction services in low- and middle-income countries	12
Practical implications of naloxone knowledge among suburban people who use opioids	12
Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon	12
To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities	12
Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network	11
Implementation of a nurse-led overdose prevention site in a hospital setting: lessons learned from St. Paul’s Hospital, Vancouver, Canada	11
“They're causing more harm than good”: a qualitative study exploring racism in harm reduction through the experiences of racialized people who use drugs	11
Gendered perspectives on women’s anabolic–androgenic steroid (AAS) usage practices	11
Reducing the harms of xylazine: clinical approaches, research deficits, and public health context	11
Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017–2019	11
Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage	11
Effect of Massachusetts House Bill No. 4196 on electronic cigarette use: a mixed-methods study	11
Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders	11
Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs	11
“Prevention of opioid use disorder: the HOME (housing, opportunities, motivation and engagement) feasibility study”	11
Reporting on the opioid crisis (2000–2018): role of The Globe and Mail, a Canadian English-language newspaper in influencing public opinion	11
The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study	11
A drug-related Good Samaritan Law and calling emergency medical services for drug overdoses in a Canadian setting	10
Hospital admissions among people who inject opioids following syringe services program implementation	10
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report	10
“You know, we can change the services to suit the circumstances of what is happening in the world”: a rapid case study of the COVID-19 response across city centre homelessness and health services in E	10
The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia	10
Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study	10
Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study	10
Predictors of skin and soft tissue infections among sample of rural residents who inject drugs	10
The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases	10
How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey	10
Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study	10
Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran	10
Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities liv	10
Integration of a community-based harm reduction program into a safety net hospital: a qualitative study	10
Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study	10
“It’s called overamping”: experiences of overdose among people who use methamphetamine	9
Methamphetamine use and HIV risk behavior among men who inject drugs: causal inference using coarsened exact matching	9
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis	9
The relationship between police contacts for drug use-related crime and future arrests, incarceration, and overdoses: a retrospective observational study highlighting the need to break the vicious cyc	9
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state	9
Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada	9
«One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment	9
A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting	9
How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation	9
HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service	9
Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis	9
Electronic cigarettes in standard smoking cessation treatment by tobacco counselors in Flanders: E-cigarette users show similar if not higher quit rates as those using commonly recommended smoking ces	9
A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South	9
Cannabis use, sedentary behavior, and physical activity in a nationally representative sample of US adults	9
Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City	8
Total systems failure: police officers’ perspectives on the impacts of the justice, health, and social service systems on people who use drugs	8
A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction	8
Reported patterns of vaping to support long-term abstinence from smoking: a cross-sectional survey of a convenience sample of vapers	8
Managed alcohol: one community’s innovative response to risk management during COVID-19	8
Prisoners should not be left behind in HCV research and policies	8
Investigation on heroin and cocaine quality in Luxembourg	8
Injections and infections: understanding syringe service program utilization in a rural state	8
Harm reduction must be recognised an essential public health intervention during crises	8
Food access among people who inject drugs in West Virginia	8
Naloxone administration by law enforcement officers in New York State (2015–2020)	8
Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations	8
What are the ethical implications of using prize-based contingency management in substance use? A scoping review	8
Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability	8
The “goldfish bowl”: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting	7
Non-beverage alcohol consumption among individuals experiencing chronic homelessness in Edmonton, Canada: a cross-sectional study	7
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine	7
Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population	7
Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?	7
Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs	7
Safer opioid supply: qualitative program evaluation	7
Supervised consumption sites and crime: scrutinizing the methodological weaknesses and aberrant results of a government report in Alberta, Canada	7
The impact of Taiwan’s implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017	7

“They don’t go by the law around here”: law enforcement interactions after the legalization of syringe services programs in North Carolina	7
Seeking safety: a focus group study of young adults’ cannabis-related attitudes, and behavior in a state with legalized recreational cannabis	7
Identifying drivers of increasing opioid overdose deaths among black individuals: a qualitative model drawing on experience of peers and community health workers	7
Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?	7
Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan	7
Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities	7
A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics	7
Correlates of recent nonfatal overdose among people who inject drugs in West Virginia	7
Challenges for drug checking services in Scotland: a qualitative exploration of police perceptions	7
“It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply	7
Decolonizing harm reduction	7
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	7
Harm reduction in the Heartland: public knowledge and beliefs about naloxone in Nebraska, USA	7
Third party drug checking: accessing harm reduction services on the behalf of others	6
Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study	6
Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada	6
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19	6
Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria	6
Can alternative nicotine products put the final nail in the smoking coffin?	6
Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators	6
Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico	6
Baseline characteristics of people experiencing homelessness with a recent drug overdose in the PHOENIx pilot randomised controlled trial	6
Principles of condom provision programs in prisons from the standpoint of European prison health experts: a qualitative study	6
High levels of used syringe use and unsafe sex among people who inject drugs in Kumasi, Ghana: an urgent call for a comprehensive harm reduction approach	6
Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study	6
Heroin pipe distribution to reduce high-risk drug consumption behaviors among people who use heroin: a pilot quasi-experimental study	6
Reducing the smoking-related health burden in the USA through diversion to electronic cigarettes: a system dynamics simulation study	6
Development of a digital platform to improve community response to overdose and prevention among harm reduction organizations	6
Responding to a surge in overdose deaths: perspectives from US syringe services programs	6
Scoping review of managed alcohol programs	6
Examining common mental health disorders in people living with HIV on methadone maintenance therapy in Hanoi, Vietnam	6
Retention and outcomes for clients attending a methadone clinic in a resource-constrained setting: a mixed methods prospective cohort study in Imphal, Northeast India	6
An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA) in Ireland	6
Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky	6
The drug war must end: The right to life, liberty and security of the person during the COVID-19 pandemic for people who use drugs	6
Contextual factors affecting the implementation of drug checking for harm reduction: a scoping literature review from a North American perspective	6
Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective	6
Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use:	6
Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study	6
Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis	6
Music festival drug checking: evaluation of an Australian pilot program	6
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation	6
Motivations, dating app relationships, unintended consequences and change in sexual behaviour in dating app users at an Australian music festival	6
Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada	5
Signals of increasing co-use of stimulants and opioids from online drug forum data	5
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes	5
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	5
Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada	5
Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina	5
“Treated like a Human Being”: perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City	5
‘Why would we not want to keep everybody safe?’ The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland	5
Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada	5
A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement	5
Determining the feasibility for an overdose prevention line to support substance users who use alone	5
“The new normal has become a nonstop crisis”: a qualitative study of burnout among Philadelphia’s harm reduction and substance use disorder treatment workers during the COVID-19 pandemic	5
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	5
Snus cessation patterns - a long-term follow-up of snus users in Sweden	5
Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia	5
Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study	5
“If I knew I could get that every hour instead of alcohol, I would take the cannabis”: need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs	5
Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris: a mixed-method analysis from the ANRS-Coquelicot study	5
Mortality among male cigar and cigarette smokers in the USA	5
Hospital admissions and mortality due to complications of injection drug use in two hospitals in Regina, Canada: retrospective chart review	5
Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder	5
Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City	5
“We were building the plane as we were flying it, and we somehow made it to the other end”: syringe service program staff experiences and well-being during the COVID-19 pandemic	5
“We need to build a better bridge”: findings from a multi-site qualitative analysis of opportunities for improving opioid treatment services for youth	5
Retention in the Austrian opioid agonist treatment system: a national prospective cohort study	5
Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency	5
Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin	5
Exploring the experience of inpatients with severe alcohol use disorder on a managed alcohol program (MAP) at St. Paul’s Hospital	5
A cultural and political difference: comparing the racial and social framing of population crack cocaine use between the United States and France	5
Best interests and low thresholds: legal and ethical issues relating to needle and syringe services for under 18s in Sweden	4
The study of feasibility and acceptability of using HIV self-tests in high-risk Iranian populations (FSWs, MSM, and TGs): a cross-sectional study	4
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study	4
Interim opioid agonist treatment for opioid addiction: a systematic review	4
More evidence or stronger political will: exploring the feasibility of needle and syringe programs in Ukrainian prisons	4
Effect of police action on low-barrier substance use disorder service utilization	4
Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who injec	4
Opioid overdose prevention education in Texas during the COVID-19 pandemic	4
Sexualized drug injection among men who have sex with men in Madrid and Barcelona as the first episode of drug injecting	4
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study	4
Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia	4
The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience	4
“Caballo”: risk environments, drug sharing and the emergence of a hepatitis C virus epidemic among people who inject drugs in Puerto Rico	4
Factors affecting addiction severity index (ASI) among clients enrolled in methadone maintenance treatment (MMT) program in Myanmar	4
Utilization of mental health services in relation to the intention to reduce chemsex behavior among clients from an integrated sexual health services center in Taiwan	4
“There’s absolutely no downside to this, I mean, except community opposition:” A qualitative study of the acceptability of vending machines for harm reduction	4
Selling sex in the context of substance use: social and structural drivers of transactional sex among men who use opioids in Maryland	4
“I would rather do it myself”: injection initiation and current injection patterns among women who inject drugs in Tijuana, Mexico	4
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA	4
Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review	4
Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium	4
Changes in cannabis use and associated correlates during France’s first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey	4
Impact of tobacco and/or nicotine products on health and functioning: a scoping review and findings from the preparatory phase of the development of a new self-report measure	4